Advertisement

Topics

Fluxome Sciences A/S Company Profile

09:37 EST 19th December 2018 | BioPortfolio

Fluxome Sciences A/S was founded in February, 2002 with the aim of exploiting its unique technology and know-how to develop innovative and cost-effective bioprocesses. Today, a variety of molecules, ranging from pharmaceuticals and fine chemicals to food ingredients and biofuels, are produced in bioprocesses using living cells. In contrast to traditional process development using random mutation and extensive screening programs, Fluxome Sciences employs a rational targeted design of the producing microorganisms - an approach referred to as metabolic engineering - which enablesimprovement of existing bioprocesses
design of bioprocesses that replaces classical synthesis routes
design of bioprocesses for production of novel compounds
The strength of Fluxome Sciences is its technology platform that permits rapid high-throughput characterization of the properties of natural and modified organisms - often the bottleneck when developing improved organisms through metabolic engineering.

Location

Diplomvej 378
Kgs. Lyngby
DK-2800
Denmark

Contact

Phone: 45 8870 8400
Fax: 45 8870 8403
Email: info@fluxome.com


News Articles [564 Associated News Articles listed on BioPortfolio]

Roivant Sciences Raises $200 Million, Bringing its Valuation to $7 Billion

Vivek Ramaswamy’s Roivant Sciences, the umbrella company to 14 Vant companies, including Datavant, Enzyvant Sciences, Urovant Sciences and others, raised another $200 million in equity financing.

Almac Sciences: Company Activity and Sharing Risks in Collaborations

In this episode of PharmaTelevision News Review, Fintan Walton talks with Denis Geffroy, Vice President Business Development at Almac Sciences at Almac. Filmed at BioTrinity 2010 in Newbury, UK, they ...

Urovant Sciences nets $130.2mm in Nasdaq IPO

Roivant Sciences GMBH's urology-focused subsidiary Urovant Sciences Ltd. netted $130.2mm in an initial public offering of 10mm shares at $14 apiece (the low end of its $14-16 range).

#Cannabisstocks: ( $CVSI) CV Sciences, Inc.'s PlusCBD Oil featured on Oct. 3rd Episode of ‘The Dr. Oz Show'

October 9, 2018 (Investorideas.com Newswire) CV Sciences, Inc. (CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), preeminent supplier and manufacturer of hemp-derived phytocannabinoids

CV Sciences, Inc. Repays Remaining Debt

LAS VEGAS, Aug. 22, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced today that it has fully repaid the pr...

Urovant Sciences files for Nasdaq IPO

Roivant Sciences GMBH's urology-focused subsidiary Urovant Sciences Ltd. filed for an initial public offering on Nasdaq.

Alimera Sciences, Inc.: Alimera Sciences Announces Canadian Regulatory Approval for ILUVIEN(R)

ATLANTA, GA / ACCESSWIRE / November 26, 2018 / Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today a...

German Academies of Sciences offer recommendations for the reform of doctoral practices

(Leopoldina) Institutional responsibility for the doctorate at universities must be strengthened. This is the recommendation offered in the statement 'Doctorate in Transition', now available in Englis...

Clinical Trials [202 Associated Clinical Trials listed on BioPortfolio]

M-learning to Improve Professional Competencies in Health Sciences

The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia

The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

Companies [1079 Associated Companies listed on BioPortfolio]

Fluxome Sciences A/S

Fluxome Sciences A/S was founded in February, 2002 with the aim of exploiting its unique technology and know-how to develop innovative and cost-effective bioprocesses. Today, a variety of molecules, r...

Fluxome, Inc.

DVS Sciences, Inc.

DVS Sciences is a life sciences technology company that has developed and manufactures a novel technology for highly multiplexed analysis of single cells. DVS Sciences has an R&D ...

Origin Sciences Limited

Origin Sciences is a medical technology company developing innovative devices and tests to aid the detection and diagnosis of gastrointestinal diseases. Origin Sciences is based i...

T.A. Sciences

T.A. Sciences www.TASciences.com is the first company in the world to offer its clients the ability to fight aging through the emerging science of telomere biology. T.A. Sciences was founded by Noel T...

More Information about "Fluxome Sciences A/S" on BioPortfolio

We have published hundreds of Fluxome Sciences A/S news stories on BioPortfolio along with dozens of Fluxome Sciences A/S Clinical Trials and PubMed Articles about Fluxome Sciences A/S for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fluxome Sciences A/S Companies in our database. You can also find out about relevant Fluxome Sciences A/S Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...


Corporate Database Quicklinks



Searches Linking to this Company Record